Insider · CIK 0001817370
Donald F Tang
Files at RBOT (Vicarious Surgical Inc.), SNTI (Senti Biosciences, Inc.). First filing Aug 21, 2025, latest Aug 27, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RBOT: Vicarious Surgical Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Vicarious Surgical Inc. | $18k 2,753 shares | -6% | +31% from low-59% from high | |
| 30Weak | Vicarious Surgical Inc. | $13k 2,159 shares | -5% | +26% from low-61% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 26, 2025 | RBOT Vicarious Surgical Inc. | SOpen-market sale Class A Common Stock | -2,753 | $6.70 | $18k | 40,425 | Aug 27, 2025 |
| Aug 19, 2025 | RBOT Vicarious Surgical Inc. | SOpen-market sale Class A Common Stock | -100 | $6.68 | $668 | 45,237 | Aug 21, 2025 |
| Aug 20, 2025 | RBOT Vicarious Surgical Inc. | SOpen-market sale Class A Common Stock | -2,059 | $6.04 | $12k | 43,178 | Aug 21, 2025 |
| Jun 27, 2025 | RBOT Vicarious Surgical Inc. | AGrant or award Stock Option (right to buy)derivative | +5,335 | $0.00 | $0 | 5,335 | Aug 11, 2025 |
| Jun 25, 2025 | SNTI Senti Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +21,950 | $0.00 | $0 | 21,950 | Jun 27, 2025 |
| Dec 9, 2024 | SNTI Senti Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Dec 10, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.